Search
Search Results
##search.searchResults.foundPlural##
-
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2547PDF: 1646HTML: 712 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2393PDF: 1371HTML: 17210Bassan Fig.1: 166Bassan Fig.2: 273Bassan Fig.4: 161Fig.3: 232 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3016PDF: 1420HTML: 3728Untitled: 224Untitled: 232Untitled: 206 -
LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE
1409PDF: 947HTML: 1301fig 1A: 215figure1B: 184 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4646PDF: 1695HTML: 4298Tables and Images: 265 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2330PDF: 983HTML: 6861Figure 1: 202 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3896PDF: 1549HTML: 350 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2994PDF: 1058HTML: 5645 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2621PDF: 1768HTML: 600 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2701PDF: 907HTML: 2137 -
-
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1689PDF: 1928Suppl. Files: 219HTML: 111 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4172PDF: 1204HTML: 2111Fig.1: 232Fig. 2: 128Table 1: 229Table2: 247Table 3: 227 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2203PDF: 1359HTML: 3516 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2252PDF: 1997HTML: 527 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1114PDF: 971Suppl. Files: 620HTML: 107 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7889PDF: 2498HTML: 2122Table 1.: 255Table 2.: 262Table 3.: 243Table 4.: 239 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3804PDF: 941HTML: 6882 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1463PDF: 907HTML: 10098cover letter to the editor: 198tile page: 278 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4386Suppl. Files: 1227PDF: 1137Html: 289 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1747PDF: 860HTML: 966cover letter: 307 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1378PDF: 1102HTML: 437 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1812PDF: 1350HTML: 643 -
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.
3559PDF: 1088HTML: 1043Figure 1: 215 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
5600PDF: 1080HTML: 482TABLE: 216FIGURES: 287 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1367PDF: 622HTML: 4164 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2869PDF: 1199HTML: 3315 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4618PDF: 3800HTML: 376







